Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Gilead Dives After Its Bread-And-Butter Drug Misses Sales Forecasts
Gilead Dives After Its Bread-And-Butter Drug Misses Sales Forecasts · Investor's Business Daily

In This Article:

Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell in late action.